Executive Leadership


Stephanie Bolton
President, Global Epilepsy
Stephanie Bolton
Stephanie Bolton is President, Global Epilepsy and previously served as President of LivaNova’s International Region. Ms. Bolton joined Cyberonics, a LivaNova legacy company, in 2011, where she moved into sales leadership roles and served as Vice President for multiple European markets. She also spent eight years in the pharmaceutical industry at UCB, Otsuka Pharmaceuticals, and Sankyo Pharma. Ensuring equitable patient access to the latest healthcare technologies is Ms. Bolton’s driving force. As Vice Chair of the Association of British HealthTech Industries, she advocates for sector innovation with government stakeholders. She is active in several women’s network and mentoring groups, and is known for cultivating an open, supportive culture that emphasizes diversity and inclusion.
Ms. Bolton graduated with honors from Coventry University with a degree in physiology.
Stephanie Bolton


Michael Hutchinson
Senior Vice President, Chief Legal Officer and Company Secretary
Michael Hutchinson
Michael Hutchinson is Senior Vice President, Chief Legal Officer and Company Secretary. He joined LivaNova in November 2022. He leads the Company’s global legal, compliance, and corporate governance functions, while also overseeing corporate communications and information technology and security. He has more than 20 years of experience as an attorney, advisor, and business leader, including more than a decade of leadership and management experience with life science companies such as Stryker Corporation and Varian Medical Solutions. He has successfully and efficiently managed a broad range of legal and business issues, including complex litigation, ESG matters, and government investigations. His experience also includes leading and advising on more than 80 acquisitions and integrations. Prior to his role at LivaNova, Mr. Hutchinson began his law career working in private practice.
Mr. Hutchinson holds a Juris Doctor degree from The George Washington University Law School and a Bachelor of Arts from Clark University.
Michael Hutchinson


Philip Kowalczyk
Chief Strategy and Corporate Development Officer
Philip Kowalczyk
Mr. Kowalczyk earned a bachelor’s degree in politics from Princeton University and holds an MBA in finance and strategy from The University of Michigan’s Stephen M. Ross School of Business.
Philip Kowalczyk


Natalia Kozmina
Chief Human Resources Officer
Natalia Kozmina
Ms. Kozmina holds an undergraduate degree in chemistry from M.V. Lomonosov Moscow State University, a postgraduate degree in chemistry from The Ohio State University, and an MBA from The University of Chicago’s Booth School of Business.
Natalia Kozmina


Sujay Mashru
Senior Vice President, APAC and Growth Markets
Sujay Mashru
Sujay Mashru is Senior Vice President of Asia Pacific (APAC) and Growth Markets, where he leads all commercial activities for the APAC, Middle East, Africa, Russia, and Latin American regions. Previously, he served as Vice President of APAC for LivaNova, overseeing the rapid expansion of the business in more than 20 countries. He joined LivaNova in 2012 as part of the Corporate Development team, focusing on corporate strategic planning, mergers, and acquisitions. In 2015, he became Vice President of Commercial Operations for the International Region, where he managed business transformation projects, commercial strategy, channel partner management, and commercial excellence for all business units. Before joining LivaNova, Mr. Mashru spent seven years with Medtronic in its Cardiac Rhythm Disease Management division in commercial and engineering roles.
Mr. Mashru earned a Bachelor of Science in electrical engineering from Purdue University and an MBA from INSEAD (Institut Européen d'Administration des Affaires).
Sujay Mashru


Franco Poletti
President, Cardiopulmonary
Franco Poletti
Franco Poletti is President, Cardiopulmonary at LivaNova, a position he assumed in July 2024. He began his career more than 30 years ago at Sorin Group, one of LivaNova’s legacy companies, and has since held multiple senior leadership roles. Over the past two decades, he served as Global Product Manager; Vice President, Sales, Europe, and Japan; Vice President, Sales, Europe; Vice President, Sales, Cardiopulmonary Europe; and Interim President, Cardiopulmonary. In addition to Cardiopulmonary, he has overseen other business franchises including Heart Valves, Cardiac Rhythm Management, and Neuromodulation. Mr. Poletti has developed core competencies in product development, market positioning, product launches, and sales execution. His career reflects a strong track record of operational leadership and commercial excellence across global markets.
Mr. Poletti graduated from Istituto Tecnico Industriale G. Galilei in Mirandola, Italy.
Franco Poletti


Alex Shvartsburg
Chief Financial Officer
Alex Shvartsburg
Alex Shvartsburg is the Chief Financial Officer of LivaNova, leading finance, accounting, and investor relations. From November 2020 to July 2021, he served as the interim Chief Financial Officer of LivaNova. Prior to his appointment to the role, he led the LivaNova Corporate Financial Planning and Analysis group and was the International Region CFO. Before joining LivaNova in 2017, Mr. Shvartsburg was CFO and Chief Operating Officer of Caligor, a private equity-backed clinical services organization, where he was responsible for the Finance, Operations, Human Resources, and Information Technology functions. Before that, he held finance leadership roles, including the role of CFO, within the Genetic Sciences division at Thermo Fisher Scientific, Senior Finance Director M&A at Life Technologies, and for over 20 years, he held a series of finance roles of increasing responsibility within Johnson & Johnson.
Mr. Shvartsburg earned a Bachelor of Science degree in Accounting from Drexel University and an MBA from LaSalle University. He is a Certified Management Accountant.
Alex Shvartsburg


Ahmet Tezel
Chief Innovation Officer
Ahmet Tezel
Dr. Tezel earned bachelor’s and master’s degrees in chemical engineering from Bogazici University in Türkiye and a doctorate in chemical engineering from The University of California-Santa Barbara in the field of transdermal drug delivery and vaccination.
Ahmet Tezel
